个人简介
Pasquale Vergara是IRCCS圣拉斐尔科学研究医院心脏心律失常与电生理科的心脏病(心率失常)医生,在Paolo della Bella医生的指导下开展工作。
2001年,Vergara医生以优异成绩从那不勒斯腓特烈二世大学医学院毕业,2005年又在该校获得心脏病学专业学位,后在那不勒斯第二大学获得心脏呼吸系统及相关生物技术医学生理病理学医学博士学位。
临床上,Vergara医生是复杂心律失常标测和介入治疗的专家。他还负责运动员心律失常中心的协调工作,该中心专为专业及业余运动员设计。Vergara医生负责对房颤、阵发性室上性心动过速、左右心房扑动、室性期外收缩、室性心动过速进行消融手术,并植入起搏器、除颤器和CRT。此外,他还负责进行零X射线程序(不使用X射线的程序)和植入无线双心室设备。
其研究活动重点关注:室性心动过速消融的先进方法、成功导管消融的预测因素、运动员心律失常、致心律失常性发育不良。
Vergara医生还是IVTCC(胃肠道消融中心国际联合小组)(正式)和意大利心律失常医师协会房颤研究组的成员。
他以作者身份在意大利国内外期刊上发表了多篇原创科研论文,也参与了书籍章节的编写。H指数为22。他经常参加意大利国内外的行业会议,并担任发言人和主持人。
出版物
最新出版物
Are Atrial High-Rate Episodes Associated With Increased Risk of Ventricular Arrhythmias and Mortality?
J Am Coll Cardiol EP 2019;5:1197–208. DOI: 10.1016/j.jacep.2019.06.018 PubMed ID: 31648745
Nationwide survey on the current practice of ventricular tachycardia ablation.
J Cardiovasc Med (Hagerstown) 2019;20:597-605. doi: 10.2459/JCM.0000000000000830. PMID:31318839 ScopusID: 2-s2.0-85070655747 WOS:000485539600003
Predictive score for identifying survival and recurrence risk profiles in patients undergoing ventricular tachycardia ablation: the I-VT score.
Circulation Arrhythmia Electrophysiology. 2018;11:e006730 DOI: 10.1161/CIRCEP.118.006730 PMID: 30562104.
Predictors of zero x-ray ablation for supraventricular tachycardias in A nationwide multicenter experience.
Circulation Arrhythmia Electrophysiology 2018;11:e005592. DOI: 10.1161/CIRCEP.117.005592 PMID: 29874166 Scopus: 2-s2.0-85053418065 WOS: 000427863500003
Successful Ventricular Tachycardia Ablation In Patients With Electrical Storm Reduces Recurrences And Improves Survival.
Heart Rhythm. 2018;15:48-55 doi: 10.1016/j.hrthm.2017.08.022. PMID: 28843418;
Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study.
Heart Rhythm 2015; 12: 1997-2007.
Outcomes of Catheter Ablation of Ventricular Tachycardia Based on Etiology in Nonischemic Heart Disease: An International Ventricular Tachycardia Ablation Center Collaborative Study.
JACC Clin Electrophysiol. 2018;4:1141-1150. doi: 10.1016/j.jacep.2018.05.007. PMID: 30236386 Scopus: 2-s2.0-85052960048.
Usefulness of electroanatomical mapping with contact force monitoring for accessory pathways ablation in pediatric population.
Pediatric Cardiol 2019;40(4):713-718. DOI: 10.1007/s00246-019-02051-0 PMID:30666358 Scopus:2-s2.0-85060336792 WOS:000463707500005
Late potentials abolition as an additional technique for reduction of arrhythmia recurrence in scar related ventricular tachycardia ablation.
J Cardiovasc Elec-trophysiol 2012;23:621-7.
The Subcutaneous ICD: A Niche Indication or the Next Contender of the Transvenous ICD?
J Cardiovasc Electrophysiol 2013;24:83-5
Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias. Long term outcome of the ablation procedure.
Circulation 2013;127:1359-68.
Radiofrequency and cryoenergy endo-epicardical catheter and surgical approach for a case of incessant ventricular tachycardia ablation.
Europace. 2013;15(4):540.
Genetics can contribute to the prognosis of Brugada syndrome: a pilot model for risk stratification.
Eur J Hum Genet. 2013;21:911-7.
Management of atrial fibrillation.
F1000Prime Reports 2014, 6:22 (doi:10.12703/P6-22)
Acute and one year outcome of premature ventricular contraction ablation guided by contact force and automated pacemapping software.
Journal Arrhythmias 2019;35:542–549. DOI: 10.1002/joa3.12194 PMID: 31293706.